Skip to content
Asklepios Bio and Bayer

Asklepios Bio and Bayer

AAV2-GDNF is a gene therapy that delivers GDNF (glial cell line-derived neurotrophic factor) agonists to enhance neuron survival and regeneration, particularly for dopamine-producing neurons, aiming to slow disease progression.

Cart 0

Your cart is currently empty.

Start Shopping